Mitochondrial diseases: causes and solutions (literature review)

Abstract

The discovery of mitochondrial desoxyribonucleic acid (DNA) mutations and the association of these mutations with the development of severe, sometimes, fatal diseases led to new forms of reproductive technologies, i.e., mitochondrial replacement therapy. Currently, researchers are investigating three main methods of mitochondrial replacement therapy: pronuclear transfer, maternal spindle transfer, and polar body genome transfer. Thanks to these methods, the transmission of faulty mitochondrial DNA from the mother to the next generation can be prevented, with the main goal of developing a healthy offspring free of genetic disorders and lethal mitochondrial diseases. However, the implementation of these technologies has raised several moral, social, and cultural concerns, as it marks the emergence of a child with genetic material from three parents for the first time. This review presents an objective summary of the causes of mitochondrial disorders and various techniques employed in mitochondrial replacement therapy, along with their outcomes.

Keywords

mitochondrial diseases / mitochondrial DNA / mitochondrial replacement therapy / three-parent child / review

References

[1] Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature. 1988;331(6158):717–719. doi: 10.1038/331717a0

[2] Holt I.J., Harding A.E., Morgan-Hughes J.A. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies // Nature. 1988. Vol. 331, N. 6158. P. 717–719. doi: 10.1038/331717a0

[3] Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science. 1988;242(4884):1427–1430. doi: 10.1126/science.3201231

[4] Wallace D.C., Singh G., Lott M.T., et al. Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy // Science. 1988. Vol. 242, N. 4884. P. 1427–1430. doi: 10.1126/science.3201231

[5] Kang E, Wu J, Gutierrez NM, et al. Mitochondrial replacement in human oocytes carrying pathogenic mitochondrial DNA mutations. Nature. 2016;540(7632):270–275. doi: 10.1038/nature20592

[6] Kang E., Wu J., Gutierrez N.M., et al. Mitochondrial replacement in human oocytes carrying pathogenic mitochondrial DNA mutations // Nature. 2016. Vol. 540, N. 7632. P. 270–275. doi: 10.1038/nature20592

[7] Tavare A. Scientists are to investigate “three parent IVF” for preventing mitochondrial diseases. BMJ. 2012;344:e540. doi: 10.1136/bmj.e540

[8] Tavare A. Scientists are to investigate “three parent IVF” for preventing mitochondrial diseases // BMJ. 2012. Vol. 344. P. e540. doi: 10.1136/bmj.e540

[9] Pozdnyakova AA, Volodina M, Rshtuni SJ, Marchenko LA, Vysokikh MYu. Mitochondrial dysfunction as possible cause of impaired follicular development and steroidogenesis in premature ovarian insufficiency. Obstetrics, Gynecology and Reproduction. 2015;9(4):55–65. (In Russ). doi: 10.17749/2070-4968.2015.9.4.055-056

[10] Позднякова А.A., Володина М.A., Рштуни С.Д., Марченко Л.А., Высоких М.Ю. Митохондриальная дисфункция как одна из возможных причин нарушения фолликуло- и стероидогенеза при преждевременной недостаточности яичников // Акушерство, гинекология и репродукция. 2015. Т. 9, № 4. С. 55–65. doi: 10.17749/2070-4968.2015.9.4.055-056

[11] Craven L, Tang MX, Gorman GS, De Sutter P, Heindryckx B. Novel reproductive technologies to prevent mitochondrial disease. Hum Reprod Update. 2017;23(5):501–519. doi: 10.1093/humupd/dmx018

[12] Craven L., Tang M.X., Gorman G.S., De Sutter P., Heindryckx B. Novel reproductive technologies to prevent mitochondrial disease // Hum Reprod Update. 2017. Vol. 23, N. 5. P. 501–519. doi: 10.1093/humupd/dmx018

[13] Fragouli E, McCaffrey C, Ravichandran K, et al. Clinical implications of mitochondrial DNA quantification on pregnancy outcomes: a blinded prospective non-selection study. Hum Reprod. 2017;32(11):2340–2347. doi: 10.1093/humrep/dex292

[14] Fragouli E., McCaffrey C., Ravichandran K., et al. Clinical implications of mitochondrial DNA quantification on pregnancy outcomes: a blinded prospective non-selection study // Hum Reprod. 2017. Vol. 32, N. 11. P. 2340–2347. doi: 10.1093/humrep/dex292

[15] Xu L, Shi R. Weigh and wait: the prospect of mitochondrial gene replacement. Hum Fertil (Camb). 2016;19(4):222–229. doi: 10.1080/14647273.2016.1230234

[16] Xu L., Shi R. Weigh and wait: the prospect of mitochondrial gene replacement // Hum Fertil (Camb). 2016. Vol. 19, N. 4. P. 222–229. doi: 10.1080/14647273.2016.1230234

[17] DiMauro S. A Brief History of Mitochondrial Pathologies. Int J Mol Sci. 2019;20(22):5643. doi: 10.3390/ijms20225643

[18] DiMauro S. A Brief History of Mitochondrial Pathologies // Int J Mol Sci. 2019. Vol. 20, N. 22. P. 5643. doi: 10.3390/ijms20225643

[19] Rebolledo-Jaramillo B, Su MS, Stoler N, et al. Maternal age effect and severe germ-line bottleneck in the inheritance of human mitochondrial DNA. Proc Natl Acad Sci U S A. 2014;111(43):15474–15479. doi: 10.1073/pnas.1409328111

[20] Rebolledo-Jaramillo B., Su M.S., Stoler N., et al. Maternal age effect and severe germ-line bottleneck in the inheritance of human mitochondrial DNA // Proc Natl Acad Sci U S A. 2014. Vol. 111, N. 43. P. 15474–15479. doi: 10.1073/pnas.1409328111

[21] Mitalipov S, Amato P, Parry S, Falk MJ. Limitations of preimplantation genetic diagnosis for mitochondrial DNA diseases. Cell Rep. 2014;7(4):935–937. doi: 10.1016/j.celrep.2014.05.004

[22] Mitalipov S., Amato P., Parry S., Falk M.J. Limitations of preimplantation genetic diagnosis for mitochondrial DNA diseases // Cell Rep. 2014. Vol. 7, N. 4. P. 935–937. doi: 10.1016/j.celrep.2014.05.004

[23] Rebrikov DV. Human Genome Editing // Bulletin of RSMU. 2016;(3):4–15. (In Russ). doi: 10.24075/brsmu.2016-03-01

[24] Ребриков Д.В. Редактирование генома человека // Вестник РГМУ. 2016. № 3. С. 4–15. doi: 10.24075/brsmu.2016-03-01

[25] Wolf DP, Mitalipov N, Mitalipov S. Mitochondrial replacement therapy in reproductive medicine. Trends Mol Med. 2015;21(2):68–76. doi: 10.1016/j.molmed.2014.12.001

[26] Wolf D.P., Mitalipov N., Mitalipov S. Mitochondrial replacement therapy in reproductive medicine // Trends Mol Med. 2015. Vol. 21, N. 2. P. 8–76. doi: 10.1016/j.molmed.2014.12.001

[27] Haimes E, Taylor K. Sharpening the cutting edge: additional considerations for the UK debates on embryonic interventions for mitochondrial diseases. Life Sci Soc Policy. 2017;13(1):1. doi: 10.1186/s40504-016-0046-2

[28] Haimes E., Taylor K. Sharpening the cutting edge: additional considerations for the UK debates on embryonic interventions for mitochondrial diseases // Life Sci Soc Policy. 2017. Vol. 13, N. 1. P. 1. doi: 10.1186/s40504-016-0046-2

[29] Sharma H, Singh D, Mahant A, et al. Development of mitochondrial replacement therapy: A review. Heliyon. 2020;6(9):e04643. doi: 10.1016/j.heliyon.2020.e04643

[30] Sharma H., Singh D., Mahant A., et al. Development of mitochondrial replacement therapy: A review // Heliyon. 2020. Vol. 6, N. 9. P. e04643. doi: 10.1016/j.heliyon.2020.e04643

[31] Nagpal M, Kaur S. Recent Advancement in Human Reproduction Three-parent Babies: A Technique to Neutralize Mitochondrial Disease Load ― A Boon or a Bane for Society? Curry Trends Diagn Treat. 2017;1(2):100–103. doi: 10.5005/jp-journals-10055-0024

[32] Nagpal M., Kaur S. Recent Advancement in Human Reproduction Three-parent Babies: A Technique to Neutralize Mitochondrial Disease Load ― A Boon or a Bane for Society? // Curry Trends Diagn Treat. 2017. Vol. 1, N. 2. P. 100–103. doi: 10.5005/jp-journals-10055-0024

[33] Labarta E, de Los Santos MJ, Escriba MJ, Pellicer A, Herriaz S. Mitochondria as a tool for oocyte rejuvenation. Fertil Steril. 2019;111(2):219–226. doi: 10.1016/j.fertnstert.2018.10.036

[34] Labarta E., de Los Santos M.J., Escriba M.J., Pellicer A., Herriaz S. Mitochondria as a tool for oocyte rejuvenation // Fertil Steril. 2019. Vol. 111, N. 2. P. 219–226. doi: 10.1016/j.fertnstert.2018.10.036

[35] Jose F, Lekshmi S, Lal S, Jjiju V, Abraham E. Three parent child: a review. Inter J Novel Trends in Pharmaceutical Sciences. 2017;7(2):54–56.

[36] Jose F., Lekshmi S., Lal S., Jjiju V., Abraham E. Three parent child: a review // Inter J Novel Trends in Pharmaceutical Sciences. 2017. Vol. 7, N. 2. P. 54–56.

[37] Schmerler S, Wessel GM. Polar bodies ― more a lack of understanding than a lack of respect. Mol Reprod Dev. 2011;78(1):3–8. doi: 10.1002/mrd.21266

[38] Schmerler S., Wessel G.M. Polar Bodies ― more a lack of understanding than a lack of respect // Mol Reprod Dev. 2011. Vol. 78, N. 1. P. 3–8. doi: 10.1002/mrd.21266

[39] Afanas’ev YuI, Yurina NA, Kotovskii EF, et al. Histology, Embryology, Cytology: Textbook. 6th ed., reprint. and add. Afanas’ev YuI, Yurina NA, editors. Chapter 20. The Sexual System. Moscow; 2012. (In Russ). (electronic version: http://vmede.org/sait/?id=Gistologiya_embriol_cit_afanasev_2012&menu=Gistologiya_embriol_cit_afanasev_2012&page=24)

[40] Афанасьев Ю.И., Юрина Н.А., Котовский Е.Ф., и др. Гистология, эмбриология, цитология: учебник / под ред. Ю.И. Афанасьева, Н.А. Юриной. 6-е изд., перераб. и доп. Глава 20. Половая система. Москва, 2012. (электронная версия: http://vmede.org/sait/?id=Gistologiya_embriol_cit_afanasev_2012&menu=Gistologiya_embriol_cit_afanasev_2012&page=24)

[41] Wang T, Sha H, Ji D, et al. Polar body genome transfer for preventing the transmission of inherited mitochondrial diseases. Cell. 2014;157(7):1591–1604. doi: 10.1016/j.cell.2014.04.042

[42] Wang T., Sha H., Ji D., et al. Polar body genome transfer for preventing the transmission of inherited mitochondrial diseases // Cell. 2014. Vol. 157, N. 7. P. 1591–1604. doi: 10.1016/j.cell.2014.04.042

[43] Ma H, O’Neil RC, Gutierrez NM, et al. Functional Human Oocytes Generated by Transfer of Polar Body Genomes. Cell Stem Cell. 2017;20(1):112–119. doi: 10.1016/j.stem.2016.10.001

[44] Ma H., O’Neil R.C., Gutierrez N.M., et al. Functional Human Oocytes Generated by Transfer of Polar Body Genomes // Cell Stem Cell. 2017. Vol. 20, N. 1. P. 112–119. doi: 10.1016/j.stem.2016.10.001

[45] Hamzelou J. ‘3-parent baby’ Success. New Sci. 2016;232(3093):8–9. doi: 10.1016/s0262-4079(16)31769-9

[46] Hamzelou J. ‘3-parent baby’ Success // New Sci. 2016. Vol. 232, N. 3093. P. 8–9. doi: 10.1016/s0262-4079(16)31769-9

[47] Reardon S. Genetic details of controversial ‘three-parent baby’ revealed. Nature. 2017;544(7648):17–18. doi: 10.1038/nature.2017.21761

[48] Reardon S. Genetic details of controversial ‘three-parent baby’ revealed // Nature. 2017. Vol. 544, N. 7648. P. 17–18. doi: 10.1038/nature.2017.21761

[49] Dockrill P. World-First in Ukraine as ‘Three-Parent Baby’ Born to an Infertile Couple. Science Alert. 2017 January 19 [cited 2023 Seрt. 25]. Available from: https://www.sciencealert.com/world-first-in-ukraine-as-three-parent-baby-born-to-an-infertile-couple/

[50] Dockrill P. World-First in Ukraine as ‘Three-Parent Baby’ Born to an Infertile Couple // Science Alert. 2017. Доступ по ссылке: https://www.sciencealert.com/world-first-in-ukraine-as-three-parent-baby-born-to-an-infertile-couple/ Дата обращения: 25.09.2023.

[51] Dahiya N, Garg S. Three-parent baby: Is it ethical? Indian J Med Ethics. 2018;3(2):169. doi: 10.20529/IJME.2017.097

[52] Dahiya N., Garg S. Three-parent baby: Is it ethical? // Indian J Med Ethics. 2018. Vol. 3, N. 2. P. 169. doi: 10.20529/IJME.2017.097

RIGHTS & PERMISSIONS

Eco-Vector